Literature DB >> 11687886

Functional interactions and signaling properties of mammalian DNA mismatch repair proteins.

A Bellacosa1.   

Abstract

The mismatch repair (MMR) system promotes genomic fidelity by repairing base-base mismatches, insertion-deletion loops and heterologies generated during DNA replication and recombination. This function is critically dependent on the assembling of multimeric complexes involved in mismatch recognition and signal transduction to downstream repair events. In addition, MMR proteins coordinate a complex network of physical and functional interactions that mediate other DNA transactions, such as transcription-coupled repair, base excision repair and recombination. MMR proteins are also involved in activation of cell cycle checkpoint and induction of apoptosis when DNA damage overwhelms a critical threshold. For this reason, they play a role in cell death by alkylating agents and other chemotherapeutic drugs, including cisplatin. Inactivation of MMR genes in hereditary and sporadic cancer is associated with a mutator phenotype and inhibition of apoptosis. In the future, a deeper understanding of the molecular mechanisms and functional interactions of MMR proteins will lead to the development of more effective cancer prevention and treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11687886     DOI: 10.1038/sj.cdd.4400948

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  59 in total

1.  Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin.

Authors:  Hideki Shimodaira; Atsuko Yoshioka-Yamashita; Richard D Kolodner; Jean Y J Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

2.  MED1: a central molecule for maintenance of genome integrity and response to DNA damage.

Authors:  Barbara L Parsons
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

3.  Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage.

Authors:  Eugene S Kandel; Jennifer Skeen; Nathan Majewski; Antonio Di Cristofano; Pier Paolo Pandolfi; Claudine S Feliciano; Andrei Gartel; Nissim Hay
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

4.  The alternating ATPase domains of MutS control DNA mismatch repair.

Authors:  Meindert H Lamers; Herrie H K Winterwerp; Titia K Sixma
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

5.  EXO1-dependent single-stranded DNA at telomeres activates subsets of DNA damage and spindle checkpoint pathways in budding yeast yku70Delta mutants.

Authors:  Laura Maringele; David Lydall
Journal:  Genes Dev       Date:  2002-08-01       Impact factor: 11.361

6.  Dimerization of MLH1 and PMS2 limits nuclear localization of MutLalpha.

Authors:  Xiaosheng Wu; Jeffrey L Platt; Marilia Cascalho
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

7.  Signaling from DNA mispairs to mismatch-repair excision sites despite intervening blockades.

Authors:  Huixian Wang; John B Hays
Journal:  EMBO J       Date:  2004-04-22       Impact factor: 11.598

8.  Asymmetric ATP binding and hydrolysis activity of the Thermus aquaticus MutS dimer is key to modulation of its interactions with mismatched DNA.

Authors:  Edwin Antony; Manju M Hingorani
Journal:  Biochemistry       Date:  2004-10-19       Impact factor: 3.162

9.  Identification of the mismatch repair genes PMS2 and MLH1 as p53 target genes by using serial analysis of binding elements.

Authors:  Jiguo Chen; Ivan Sadowski
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

10.  Microsatellite instability predicts clinical outcome in radiation-treated endometrioid endometrial cancer.

Authors:  Cristina Bilbao; Pedro Carlos Lara; Raquel Ramírez; Luis Alberto Henríquez-Hernández; Germán Rodríguez; Orlando Falcón; Laureano León; Manuel Perucho; Bonifacio Nicolás Díaz-Chico; Juan Carlos Díaz-Chico
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-01       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.